Target Name: Short transient receptor potential channel (TrpC)
NCBI ID: P6293
Review Report on Short transient receptor potential channel (TrpC) Target / Biomarker Content of Review Report on Short transient receptor potential channel (TrpC) Target / Biomarker
Short transient receptor potential channel (TrpC)
Other Name(s): TrpC | TRPC | Transient receptor protein | Transient receptor potential cation channel, subfamily C

TRP-C: A Protein Playing A Role in Cellular Signaling and Disease

Short Transient Receptor Potential Channel (TRP) is a protein that plays an important role in cellular signaling. It is a family of transmembrane proteins that are characterized by their short, transient receptor potentials. These channels are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and intracellular signaling.

One of the TRP channels is TRP-C (nonspecific subtype), which is a protein that is expressed in many different tissues and cells. It is characterized by its ability to modulate the activity of other proteins, particularly those that are involved in cell signaling pathways. This protein has been shown to play a role in a wide range of biological processes, including the regulation of pain, anxiety, and depression.

TRP-C is a non-selective TRP channel that can be activated by a variety of different molecules. This means that it can be used as a drug target or biomarker for a wide range of different diseases. For example, TRP-C has been shown to be involved in the regulation of pain perception, and it has been shown to play a role in the development of anxiety and depression.

One of the key benefits of TRP-C as a drug target is its ability to modulate the activity of other proteins. This means that it can be used to treat a wide range of different diseases, by targeting specific proteins that are involved in those diseases. For example, TRP-C has been shown to play a role in the regulation of pain perception, and it has been shown to interact with pain receptors. This means that TRP-C could be used to treat a wide range of pain-related diseases, including chronic pain, neuropathic pain, and pain-related anxiety.

Another potential use of TRP-C as a drug target is its ability to modulate the activity of neurotransmitters. Neurotransmitters are molecules that are used by the nervous system to communicate with other cells. TRP-C has been shown to play a role in the regulation of neurotransmitter release, and this could be used as a potential drug target for a wide range of neurotransmitter-related diseases.

TRP-C has also been shown to play a role in the regulation of intracellular signaling pathways. These pathways are the processes that occur within cells, and they are involved in a wide range of cellular processes, including cell growth, apoptosis, and inflammation. TRP-C has been shown to play a role in the regulation of intracellular signaling pathways, and this could be used as a potential drug target for a wide range of intracellular signaling pathway-related diseases.

In addition to its potential as a drug target, TRP-C has also been shown to have a wide range of other biological functions. For example, it has been shown to play a role in the regulation of cell adhesion, cell migration, and the regulation of ion channels. These functions are important for the proper functioning of many different tissues and cells, and they could be used as potential drug targets for a wide range of different diseases.

Overall, TRP-C is a protein that has a wide range of biological functions and has been shown to play a role in a wide range of physiological processes. As a result, it is a promising drug target and biomarker for a wide range of different diseases. Further research is needed to fully understand the role of TRP-C in cellular signaling and its potential as a drug.

Protein Name: Short Transient Receptor Potential Channel (TrpC) (nonspecified Subtype)

The "Short transient receptor potential channel (TrpC) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Short transient receptor potential channel (TrpC) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SHOX | SHOX2 | SHPK | SHPRH | SHQ1 | SHROOM1 | SHROOM2 | SHROOM3 | SHROOM4 | SHTN1 | SI | SIAE | SIAH1 | SIAH2 | SIAH3 | Sialidase | Sialyltransferase | SIDT1 | SIDT2 | SIGIRR | SIGLEC1 | SIGLEC10 | SIGLEC11 | SIGLEC12 | SIGLEC14 | SIGLEC15 | SIGLEC16 | SIGLEC17P | SIGLEC5 | SIGLEC6 | SIGLEC7 | SIGLEC8 | SIGLEC9 | SIGLECL1 | sigma Receptor | SIGMAR1 | Signal peptidase complex | Signal recognition particle | Signal recognition particle receptor | Signal Transducers and Activators of Transcription (STAT) | SIK1 | SIK2 | SIK3 | SIKE1 | SIL1 | SILC1 | SIM1 | SIM2 | SIMC1 | SIN3 complex | SIN3A | SIN3B | SINHCAF | SIPA1 | SIPA1L1 | SIPA1L1-AS1 | SIPA1L2 | SIPA1L3 | SIRPA | SIRPAP1 | SIRPB1 | SIRPB2 | SIRPB3P | SIRPD | SIRPG | SIRPG-AS1 | SIRT1 | SIRT2 | SIRT3 | SIRT4 | SIRT5 | SIRT6 | SIRT7 | SIT1 | SIVA1 | SIX1 | SIX2 | SIX3 | SIX3-AS1 | SIX4 | SIX5 | SIX6 | SKA1 | SKA1 complex | SKA2 | SKA2P1 | SKA3 | SKAP1 | SKAP1-AS2 | SKAP2 | Skeletal muscle troponin | SKI | SKIC2 | SKIC3 | SKIC8 | SKIDA1 | SKIL | SKINT1L | SKOR1 | SKOR2